Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.
Stallone G, Cormio L, Netti GS, Infante B, Selvaggio O, Fino GD, Ranieri E, Bruno F, Prattichizzo C, Sanguedolce F, Tortorella S, Bufo P, Grandaliano G, Carrieri G.
Stallone G, et al.
Cancer Res. 2014 Aug 15;74(16):4230-8. doi: 10.1158/0008-5472.CAN-14-0369. Epub 2014 Jun 20.
Cancer Res. 2014.
PMID: 24950910